NEW YORK, Feb. 03, 2016 -- Levi & Korsinsky announces it has commenced an investigation of OvaScience, Inc. (NASDAQ:OVAS) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
The investigation focuses on whether OvaScience made materially false and misleading statements and/or omitted material information by failing to disclose that OvaScience’s AUGMENT procedure did not achieve a significant success rate of clinical pregnancies compared to previous rates achieved without the Company's AUGMENT procedure. Investors have suffered damages following the decline of the Company’s common stock from an offering price of $50 per share, to a recent close on January 21, 2016 of $8.74 per share. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (866) 367-6510 www.zlk.com


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 



